aXichem

The nomination committee, which consists of Anders Månsson (LMK companies) and Torsten Helsing (Manakin LTD), proposes the following:

• that lawyer Christian Lindhé or, in his absence, the person appointed by the board instead is elected as chairman of the meeting,
• that the number of board members should be seven, without deputies,
• that remuneration to the board is paid with six price base amounts to the chairman of the board and with three price base amounts each to the other board members,
• that the board members Jan Gustavsson, Torsten Helsing Christian Månsson, Jørn H. Berthelsen and Edward van den Elsen are re-elected. Gunilla Savring has declined re-election.
• that Michael Engström is elected as a new board member,
• that Jan Gustavsson is re-elected as chairman of the board,
• that the company must have an auditor, without deputies,
• that the auditor's fee is paid according to an approved current account, and
• that Mazars AB be re-elected as the company's auditor, whereby the intention is that the authorized auditor Annika Larsson will be the auditor in charge.

The nomination committee further proposes that Anders Månsson (LMK companies) and Torsten Helsing (Manakin LTD) be re-elected as members of the nomination committee ahead of the 2025 annual general meeting, and that the nomination committee should have the opportunity to decide to appoint a third member to the nomination committee, as a representative of the company's other shareholders. Such possible third member must be appointed by the chairman of the board.

Information about the board member proposed for re-election
The nomination committee proposes the re-election of Michael Engström. Michael Engström, born 1963, is CEO and co-owner of the consulting and training company Ahrens & Partners AB. He is chairman of the board of Clemondo Group AB (publ), Hammerglass AB, Här Malmö AB and board member of Gullberg & Jansson AB (publ). Michael has over 20 years of experience in sales, marketing and as CEO of several companies, both in Sweden and during his 14 years abroad, for example Axis, Audiodev and Avery-Dennison. He is a marketing economist from Lund University and has an MBA from the University of Sheffield.

___________________

Lund in June 2024

aXichem AB (publ)

The nomination committee

The information was submitted, through the agency of the contact person, for publication on June 7, 2024, at 10:15 AM CET.

For further information:

Torsten Helsing, CEO, aXichem AB, phone: +46 706 863 355, email: torsten.helsing@axichem.com

About aXichem

aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. More information is available at www.axichem.com.